The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s (GSK) Jesduvroq (daprodustat) to treat anaemia caused by chronic kidney disease (CKD) in adults who have been on dialysis for at least four months. Jesduvroq is an oral hypoxia-inducible factor...
GoodRx failed to notify users that it sold their personal health information to Google, Facebook and other tech companies, the FTC claimed. The agency filed an order that prohibits GoodRx from sharing its users’ data with third parties for advertising purposes and...
Under the proposed new rule, employers are no longer able to be exempt from offering coverage for contraception due to moral convictions, but religious exemptions still remain. It’s an important move from the government during the reproductive health crisis, one...
Instead of leaning on the arbitrary and subjective nature of prominent, perceived prestige-focused industry rankings, health systems must shift to a data-driven and mathematically sound approach to determining and benchmarking quality.
Taysha Gene Therapies has encouraging data from an open-label, Phase 1/2 study in the rare disease giant axonal neuropathy. It might not be enough. The FDA recommended the biotech conduct a randomized and placebo-controlled study—a challenge in any ultra-rare...
